Qureator, Inc.
Qureator provides integrated human disease model and AI platform to evaluate treatment efficacy in complex disease models.
Funding history
About Qureator, Inc.
How much funding has Qureator, Inc. raised?
Qureator, Inc. has raised $6.7M in total funding. The most recent round was Series A.
Where is Qureator, Inc. headquartered?
Qureator, Inc. is headquartered in San Diego, CA.
What does Qureator, Inc. do?
Qureator provides integrated human disease model and AI platform to evaluate treatment efficacy in complex disease models.
What problem does Qureator, Inc. solve?
New drug candidates need to be tested and validated on human-relevant biology before they are put into human bodies, rather than relying only on animal models.
What's Qureator, Inc.'s solution?
Qureator builds CurioChip-enabled human disease models (using human cells, patient-derived data, and omics) combined with its QuriCore AI for target identification, combination discovery, and efficacy/dosage prediction.
What makes Qureator, Inc. different?
The page cites a historic FDA IND approval achieved based on human-relevant data without animal proof-of-concept data, developed in collaboration with SillaJen, and notes Qureator was shortlisted for the Lush Prize in Science for advancing non-animal testing methods.
Leadership
❝ Cite this page
Free to use in articles, research, and reference works. Stable URL, will not change. Data on this page last updated August 26, 2026.